Related Experiment Video
Updated: Jul 18, 2026
Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
Published on: April 17, 2020
Live vaccines for human metapneumovirus designed by reverse genetics
Ursula J Buchholz1, Kunio Nagashima, Brian R Murphy
1Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 50, Room 6505, 50 South Dr. MSC 8007, Bethesda, MD 20892-8007, USA. ubuchholz@niaid.nih.gov
Developing a live-attenuated vaccine for human metapneumovirus (HMPV) is crucial for preventing severe respiratory illness in infants. Researchers are exploring various attenuation strategies, including genetic modifications and vector-based approaches, to create effective HMPV vaccines.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Human metapneumovirus (HMPV) is a significant global cause of respiratory illness, particularly in children.
- There is a critical need for an HMPV vaccine to prevent severe infant infections.
Purpose of the Study:
- To review current strategies for developing live-attenuated HMPV vaccines.
- To highlight promising vaccine candidates and their mechanisms of attenuation.
Main Methods:
- Utilizing reverse genetics to create characterized, attenuated HMPV vaccine candidates.
- Investigating different attenuation approaches: G glycoprotein deletion, M2-2 protein deletion, chimeric P protein, and vector-based strategies.
Main Results:
- Deletion of G glycoprotein leads to attenuation via reduced attachment efficiency.
- M2-2 protein deletion enhances transcription and antigen synthesis.
- Chimeric P protein introduces attenuation through host range restriction.
- Attenuated parainfluenza virus vectors can express HMPV antigens for bivalent vaccines.
Conclusions:
- Multiple promising live-attenuated HMPV vaccine candidates are under development.
- Genetic engineering and vector-based approaches offer viable pathways for HMPV vaccine creation.
- Further modifications are being explored to optimize vaccine efficacy.
